Sanofi backs Escient’s $77.5M round as it kick-starts first clinical test
Escient Pharmaceuticals has grabbed a meaty $77.5 million series B with the help of Sanofi’s VC arm as the biotech also starts its first in-human tests.
All Posts in "News Team"
Forma Therapeutics nabs new R&D execs as it plots late-stage sickle cell test next year
Heading into a pivotal year in 2021, Forma Therapeutics has hired two veterans out of Takeda and Incyte to help run its R&D programs.
Boehringer’s schizophrenia med boosts cognition in phase 2
Boehringer Ingelheim’s schizophrenia hopeful hit the mark in a phase 2 study, helping patients overcome cognitive impairment that can affect everyday tasks, such as remembering important dates or solving problems.
Pfizer tips pipeline to add $15B to sales in coming years
Pfizer has tipped its pipeline to deliver new products that add more than $15 billion to revenues by 2025. The anticipated pipeline contributions led Pfizer to predict it will weather the next wave of patent expirations that is set to start in 2026.
Gold notches back-to-back gains for highest finish in 2 weeks
Fed policy announcement due Wednesday
Tesla Inc. stock outperforms competitors on strong trading day
Shares of Tesla Inc. TSLA, +7.18% rose 7.18% to $449.76 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP, +1.20% rising 1.21% to 11,190.32 and the Dow Jones Industrial Average DJIA, +0.00% rising 0.01% to 27,995.60. This was the stock’s fifth consecutive day of gains. Tesla Inc. closed $52.73 below its 52-week high ($502.49), which the company achieved on September 1st.
Dow erases early climb, S&P 500 notches third straight gain as tech stocks extend rebound from last week’s rout
Federal Reserve begins 2-day policy meeting
Alphabet Inc. Cl A stock rises Tuesday, outperforms market
Shares of Alphabet Inc. Cl A GOOGL, +1.74% advanced 1.74% to $1,535.12 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX, +0.52% rising 0.52% to 3,401.20 and the Dow Jones Industrial Average DJIA, +0.00% rising 0.01% to 27,995.60. The stock’s rise snapped a three-day losing streak. Alphabet Inc. Cl A closed $190.98 short of its 52-week high ($1,726.10), which the company reached on September 2nd.
Nanospectra Bio nets Sirtex backing for gold nanoparticle prostate cancer therapy
Sirtex Medical, maker of a radioactive microsphere implant for treating liver tumors, has made a strategic investment in the developer of a prostate cancer therapy featuring laser-charged gold particles, Nanospectra Biosciences.
Working artificial iris could reduce light sensitivity from migraines, say Imec, Ghent University
A smart contact lens with an actively working artificial iris could become a solution for people with chronic migraines, dry eyes and oversensitivity to light, according to researchers in Belgium.
Weekly Market Review – May 18, 2024
Gain Therapeutics’ clinical Parkinson’s drug restores motor function in mice
Eli Lilly axes next-generation, resistance-busting RET inhibitor
What’s behind the rise of colorectal cancer in younger adults? Bacteria may have the answer
Vertex beats own record in cystic fibrosis as next-gen treatment goes up against Trikafta
Immunome pays $50M for phase 3 desmoid tumor drug, playing catch-up with SpringWorks
Dexcom adds upgraded One+ glucose monitoring system to European slate
Rallybio, with financial fuel levels falling, loses 45% of workforce to extend cash runway into 2026
Kyverna raises IPO expectations by $100M, now eyeing almost $300M for latest biotech listing of 2024
Deere Q2 Results Top Street but It Cuts 2024 Profit Outlook Again as Farmers Buy Fewer Tractors